213 related articles for article (PubMed ID: 1356734)
21. Differential biotransformation of glyceryl trinitrate by red blood cell-supernatant fraction and pulmonary vein homogenate.
Marks GS; McLaughlin BE; MacMillan HF; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1989 May; 67(5):417-22. PubMed ID: 2504466
[TBL] [Abstract][Full Text] [Related]
22. Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat.
Ratz JD; Fraser AB; Rees-Milton KJ; Adams MA; Bennett BM
J Pharmacol Exp Ther; 2000 Nov; 295(2):578-85. PubMed ID: 11046091
[TBL] [Abstract][Full Text] [Related]
23. Tissue levels of glyceryl trinitrate and cGMP after in vivo administration in rat, and the effect of tolerance development.
Torfgård K; Ahlner J; Axelsson KL; Norlander B; Bertler A
Can J Physiol Pharmacol; 1991 Sep; 69(9):1257-61. PubMed ID: 1661636
[TBL] [Abstract][Full Text] [Related]
24. The role of lipoic acid in prevention of nitroglycerin tolerance.
Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
[TBL] [Abstract][Full Text] [Related]
25. Biotransformation of glyceryl trinitrate by rat brain homogenate.
Marks GS; McLaughlin BE; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1992 Jun; 70(6):935-7. PubMed ID: 1423038
[TBL] [Abstract][Full Text] [Related]
26. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
Bennett BM; Kobus SM; Brien JF; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):629-35. PubMed ID: 3084763
[TBL] [Abstract][Full Text] [Related]
27. Variable glyceryl dinitrate formation following infusions of glyceryl trinitrate at different vascular sites in the rat.
Nakashima E; Lau DT; Benet LZ
Pharm Res; 1991 Jul; 8(7):877-82. PubMed ID: 1924138
[TBL] [Abstract][Full Text] [Related]
28. The effects of hypothermic and normothermic cardiopulmonary bypass on glyceryl trinitrate activity.
Booth BP; Brien JF; Marks GS; Milne B; Cervenko F; Pym J; Knight J; Rogers K; Salerno T; Nakatsu K
Anesth Analg; 1994 May; 78(5):848-56. PubMed ID: 8160981
[TBL] [Abstract][Full Text] [Related]
29. [The pharmacology and pharmacokinetics of glycerol-2-nitrate].
Leitold M; Laufen H; Yeates RA
Arzneimittelforschung; 1987 Jun; 37(6):692-8. PubMed ID: 3117068
[TBL] [Abstract][Full Text] [Related]
30. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
Bennett BM; Leitman DC; Schröder H; Kawamoto JH; Nakatsu K; Murad F
J Pharmacol Exp Ther; 1989 Jul; 250(1):316-23. PubMed ID: 2545862
[TBL] [Abstract][Full Text] [Related]
31. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates.
Slack CJ; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1989 Nov; 67(11):1381-5. PubMed ID: 2516767
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate.
McGuire JJ; Anderson DJ; McDonald BJ; Narayanasami R; Bennett BM
Biochem Pharmacol; 1998 Oct; 56(7):881-93. PubMed ID: 9774150
[TBL] [Abstract][Full Text] [Related]
33. Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance.
DiFabio J; Ji Y; Vasiliou V; Thatcher GR; Bennett BM
Mol Pharmacol; 2003 Nov; 64(5):1109-16. PubMed ID: 14573760
[TBL] [Abstract][Full Text] [Related]
34. Influence of the endothelium on ex vivo tolerance and metabolism of glyceryl trinitrate in rat aorta.
de la Lande IS; Siebert TE; Bennett CL; Stafford I; Horowitz JD
Eur J Pharmacol; 2004 Feb; 486(2):201-7. PubMed ID: 14975709
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro.
Kikkoji T; Gumbleton M; Higo N; Guy RH; Benet LZ
Pharm Res; 1991 Oct; 8(10):1231-7. PubMed ID: 1796039
[TBL] [Abstract][Full Text] [Related]
36. Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP.
Csont T; Szilvássy Z; Fülöp F; Nedeianu S; Páli T; Tosaki A; Dux L; Ferdinandy P
Br J Pharmacol; 1999 Dec; 128(7):1427-34. PubMed ID: 10602321
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous pharmacodynamic modeling of the non-steady-state effects of three oral doses of 1,3-glyceryl dinitrate upon blood pressure in healthy volunteers.
Gumbleton M; Benet LZ
J Pharmacokinet Biopharm; 1993 Oct; 21(5):515-32. PubMed ID: 8145129
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation.
MacPherson JD; Gillespie TD; Dunkerley HA; Maurice DH; Bennett BM
J Pharmacol Exp Ther; 2006 Apr; 317(1):188-95. PubMed ID: 16330494
[TBL] [Abstract][Full Text] [Related]
39. Dissociation of tissue thiols content from nitroglycerin-induced cyclic-3',5'-guanosine monophosphate and the state of tolerance: in vivo experiments in rats.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1995 Apr; 273(1):94-100. PubMed ID: 7714819
[TBL] [Abstract][Full Text] [Related]
40. The pattern of glyceryl nitrates after oral administration of glyceryl trinitrate.
Laufen H; Leitold M
Arzneimittelforschung; 1988 Jan; 38(1):103-5. PubMed ID: 3130064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
